Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that it plans to report its fiscal second quarter and six months ended financial results before the U.S. markets open on May 12, 2014.
Help employers find you! Check out all the jobs and post your resume.
